A spokesperson for Bayer Diabetes Care today confirmed that the company will stop making the device that is the best way we have to check our key blood glucose level.
When I called Susan Yarin, the spokesperson for Bayer’s diabetes care business, I asked her about the rumor that Bayer would stop making the A1CNow device at the end of the year. This device is the only way that we have to check our A1C levels at home and get immediate results.
“It’s not a rumor,” Ms. Yarin replied. “I can confirm it.”
She told me that Bayer would be closing down the facility that produces the A1CNow at the end of the year. A1CNow units “will be available as long as supplies are available.”
I told her that I was dismayed and that, since I check my A1C level on the first day of every month, I had just ordered A1CNow+ units that Bayer makes for professionals. This is the same as the A1CNow SelfCheck that Bayer makes for patients and sells in pharmacies, except the professional version includes 10 tests while the patient version includes two tests. I purchased the 10-pack kit (1 monitor and 10 test cartridges) from A1CTest for $129.00 plus $8.95 shipping and handling. That works out to $13.80 per test. Most pharmacies sell the A1CNow SelfCheck for about $30, which is $15 per test plus tax.